Chimerism after organ transplantation: Is there any clinical significance?

Clinical Transplantation

Volumn 10, Issue 1 II, 1996, Pages 110-117

  Burlingham, William J ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Chimerism; CTL dysfunction; Microchimerism; Transplantation

Indexed keywords

CD8 ANTIGEN;

APOPTOSIS; CASE REPORT; CHIMERA; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; LEUKOCYTE; MALE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT;

APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; DENDRITIC CELLS; DNA; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029939367     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. ZOLLER KM, CHO SI, VOHEN JJ, HARRINGTON JT. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 1980: 18: 110.
2. LILLIE FR. Science 1916: 43: 611.
3. OWEN RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945: 102: 400.
4. MEDAWAK PB. Immunity to homologous grafted skin. II. The relationship between the antigens of blood and skin. Br J Exp Pathol 1946: 27: 15.
5. ANDERSON D, BILLINGHAM RE, LAMPKIN GH, MEDAWAR P, The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 1951: 5: 379. Abstract.
6. BILLINGHAM RE, BRENT L, MEDAWAR PB. Actively acquired tolerance of foreign cells. Nature (London) 1953. 172: 603.
7. SIMONSEN M. The impact on the developing embryo and newborn animal of adult homologous cells. Acta Pathol Microbiol Immunol Scand 1957: 40: 480.
8. MICHIE D, WOODRUFF MFA, ZEISS IM. An investigation of immunological tolerance based on chimaera analysis. Immunology 1961: 4: 413.
9. STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, RICORDI V. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 1993: 14: 326.
10. SMELL GD. The homograft reaction. Annu Rev Microbiol 1957: 11: 439.
11. STEINMULLER D. Immunization with skin isografts taken from tolerant mice. Science 1967: 158: 127.
12. LARSEN CP, MORRIS PJ, AUSTYN JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. J Exp Med 1990: 171: 307.
13. LARSEN CP, STEINMAN MM, WITMER-PACK M, HANKINS DF, MORRIS PJ, AUSTYN JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990: 172: 1483.
14. SAIKI RK, GELFAND DH, STOFFEL S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988: 239: 487.
15. RUPERT WA, KOCOVA M, RAO AS, TRUCCO M. Fine quantitation by competitive PCR of circulating donor cells in post-transplant chimeric recipients. Transplantation 1994: 58: 964.
16. STARZL TE, DEMETRIS AJ, TRUCCO M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992: 340: 876.
17. STARZL TE, DEMETRIS AJ, TRUCCO M, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993: 328: 745.
18. COATES C. Some transplant patients survive without drugs. Daily Herald 1992: 9: 12.
19. STARZL TE, DEMETRIS AJ, TRUCCO M. et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993: 17: 1127
20. SUBERBIELLE C, CAILLAT-ZUEMAN S, LEGENDRE C, et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 1994: 343: 1468.
21. SCHLITT HJ, HUNDRIESER J, RINGE B, PICHLMAYR R. Donor type microchimerism associated with graft rejection eight years after liver transplant. N Engl J Med 1994: 330: 646.
22. MARTIN DR, MILLER RG. In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J Exp Med 1989: 170: 679-690.
23. (a) FINK PJ, SHIMONKEVITZ RP, BEVAN MJ. Veto cells. Annu Rev Immunol 1988: 6: 115.
24. (b) THOMAS J, THOMAS F. MENDEZ-PICON G, LEE H. Immunological monitoring of long-surviving renal transplant recipients. Surgery 1977: 81: 125.
25. WONIGEIT K, PICHLMAYR R. Specific defect in the capacity to generate cytotoxic effector cells in vitro after organ transplantation in man. Proc Eur Dial Transplant Assoc 1977: 6: 58.
26. 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and drugs. Immunology 1968: 14: 181.
27. BACH FH, VOYNOW NK. One-way stimulation in mixed leukocyte culture. Science 1966: 153: 545.
28. GOULMY E, BLOKLAND E, FASSBINDER W, PERSIJN G, VAN ROOD JJ. Occurrence of posttransplant donor-specific cell-mediated lympholysis nonreactivity in renal allograft recipients with perioperative transfusions only. Transplantation 1985: 39: 105.
29. REINSMOEN NL, KAUFMAN D, MATAS A, SUTHERLAND DE, NAJARIAN JS, BACH FH. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation 1990: 50: 783.
30. SEKI Y, SAKAGAMI K, TAKEUCHI H, et al. Evidence for donor-specific cell-mediated lympholysis unresponsiveness and suppressor cells in well-functioning kidney transplants. Transplant Proc 1983: 15: 2131.
31. HADLEY GA, ANDERSON CB, MOHANAKUMAR T. Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients. Transplantation 1992: 54: 333.
32. GRAILER AP, SOLLINGER HW, KAWAMURA T, BURLINGHAM WJ. Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patients pretreated with donor-specific transfusions. Transplantation 1991: 51: 320.
33. VAN TWUYVER E, MOOIJAART RJ, TEN BERGE IJ, et al. Pretransplantation blood transfusion revisited. N Engl J Med 1991: 325: 1210.
34. WALDMANN H, LEFKOVITZ I. Limiting dilution analysis of cells of the immune system. II: What can be learnt? Immunol Today 1984: 5: 295.
35. SHENG-TANNER X, MILLER RG. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. J Exp Med 1992: 176: 407.
36. GOULMY E, STIJNEN T, GROENEWOUD AF, et al. Renal transplant patients monitored by the cell-mediated lympholysis assay: evaluation of its clinical value. Transplantation 1989: 48: 559.
37. BURLINGHAM WJ, GRAILER AP, FECHNER JH Jr, et al. Microchimerism linked to cytotoxic T lymphocyte unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995: 59: 1147.
38. SOLEZ K, AXELSEN RA, BENEDIKTSSON H, et al. International standardization of criteria for the histological diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993: 44: 411.
39. THOMAS JM, CARVER M, CUNNIGHAM P, PARK K, GONDER J, THOMAS F. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor blood marrow. I. In vivo parameters and immunohistologic evidence suggesting microchimerism. Transplantation 1987: 43: 332.
40. MUNN SR, MRJORIBANKS C. Current limitations to use of major histocompatibility complex transgenic donors for islet transplantation. Transplantation 1994: 57: 760
41. KUSAKA S, GRAILER AP, FECHNER JH Jr, BURLINGHAM WJ. Analysis of cytotoxic T lymphocyte (CTL) clones from a tolerant renal transplant patient with microchimerism-linked primary CTL dysfunction. In preparation, 1995.
42. GOULMY E, BLOKLAND E, PERSIJN G. PAUL LC, WILMINK J, VAN ROOD JJ. HLA regulates postrenal transplant CML nonreactivity. J Immunol 1985: 135: 3082.
43. LU L, WOO J, RAO AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/ macrophage colony-stimulating factor and their maturational development in the presence of type-A collagen. J Exp Med (In press)
44. THOMAS JM, VERBANAC KM, SMITH JP, et al. Veto cells and the induction of transplant tolerance in primates. In: Touraine JL, ed. Rejection and Tolerance. Netherlands: Kluwer Academic Publishers, 1994: 291.
45. TAKAHASHI T, MAKI T. Prolongation of mouse skin allograft survival by cloned veto suppressor cells. Transplant Proc 1991: 23: 192.
46. JENKINS MK. The role of cell division in the induction of clonal anergy. Immunol Today 1992: 13: 69.
47. CLAAS FH, GIJBELS Y, VAN DER VELDEN-DE MUNK J, VAN ROOD JJ. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science 1988: 241: 1815.
48. HADLEY GA, PHELAN DL, DUFFY BF, MOHANAKUMAR T. Lack of T-cell tolerance of noninherited maternal HLA antigens in normal humans. Hum Immunol 1990: 28: 373.
49. SHOSKES DA, WOOD KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994: 1532: 32.
50. DEVITO-HAYNES LD, JANKOWSKA-GAN E, SOLLINGER HW, KNECHTLE SJ, BURLINGHAM WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 1994: 40: 191-201.
51. BURLINGHAM WJ, FECHNER JH JR, DEVITTO LD, SOLLINGER HW, KNECHTLE SJ, GRAILER AP. Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class I antigens in vitro: I. Specificity for polymorphic domains. Tissue Antigens 1993: 42: 35.
52. + T cells to class I heavy-chain-derived peptides. In preparation, 1995.